Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (1301-1310 of 1,389) with videos related to

Pageof 139
Sort By:
Medcomm|October 14, 2024
Single-cell transcriptome atlas revealed bronchoalveolar immune features related to disease severity in pediatric <i>Mycoplasma pneumoniae</i> pneumoniaXiantao Shen, Zhengjiang Jin, Xiaomin Chen, et al.
Medcomm|October 14, 2024
Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challengesYan Zhang, Xinyu Shi, Yifan Shen, et al.
Medcomm|October 14, 2024
Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor-mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradationFuyan Xu, Jiao Li, Min Ai, et al.
Medcomm|October 7, 2024
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targetsJun Jiang, Donghui Han, Jiawei Wang, et al.
Medcomm|September 10, 2024
Role of N6-methyladenosine RNA modification in cancerYi Qu, Nannan Gao, Shengwei Zhang, et al.
Medcomm|September 17, 2024
A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoterQian Ding, Jianghong Cai, Li Jin, et al.
Medcomm|June 2, 2023
Nontargeted metabolomics analysis of follicular fluid in patients with endometriosis provides a new direction for the study of oocyte qualityYiqiu Wei, Zhourui Zhang, Yaoyao Zhang, et al.
Medcomm|June 7, 2023
Biomaterial-based gene therapyYi Yu, Yijun Gao, Liming He, et al.
Medcomm|May 31, 2023
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studiesJinze Shen, Qurui Wang, Yunan Mao, et al.
Medcomm|March 9, 2026
Active Macropinocytosis, Lipid Catabolism, and Exhausting Immune Microenvironment of Ascites Tumor Cells Are Involved in Resistance to Platinum-Based Therapy in Patients With High-Grade Serous Ovarian CancerRuiqi Zheng, Ying Cui, Xun Hu, et al.
Pageof 139

Showing results (1301-1310 of 1,389) with videos related to

Sort By:
Pageof 139
Medcomm|October 14, 2024
Single-cell transcriptome atlas revealed bronchoalveolar immune features related to disease severity in pediatric <i>Mycoplasma pneumoniae</i> pneumoniaXiantao Shen, Zhengjiang Jin, Xiaomin Chen, et al.
Medcomm|October 14, 2024
Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challengesYan Zhang, Xinyu Shi, Yifan Shen, et al.
Medcomm|October 14, 2024
Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor-mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradationFuyan Xu, Jiao Li, Min Ai, et al.
Medcomm|October 7, 2024
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targetsJun Jiang, Donghui Han, Jiawei Wang, et al.
Medcomm|September 10, 2024
Role of N6-methyladenosine RNA modification in cancerYi Qu, Nannan Gao, Shengwei Zhang, et al.
Medcomm|September 17, 2024
A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoterQian Ding, Jianghong Cai, Li Jin, et al.
Medcomm|June 2, 2023
Nontargeted metabolomics analysis of follicular fluid in patients with endometriosis provides a new direction for the study of oocyte qualityYiqiu Wei, Zhourui Zhang, Yaoyao Zhang, et al.
Medcomm|June 7, 2023
Biomaterial-based gene therapyYi Yu, Yijun Gao, Liming He, et al.
Medcomm|May 31, 2023
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studiesJinze Shen, Qurui Wang, Yunan Mao, et al.
Medcomm|March 9, 2026
Active Macropinocytosis, Lipid Catabolism, and Exhausting Immune Microenvironment of Ascites Tumor Cells Are Involved in Resistance to Platinum-Based Therapy in Patients With High-Grade Serous Ovarian CancerRuiqi Zheng, Ying Cui, Xun Hu, et al.
Pageof 139